Category: Joint ventures/collaborations

  • Gene Editing Licensed for Inherited Disease Treatments

    26 October 2015. A Boston biotechnology company is licensing gene-editing technologies from a nearby start-up to design treatments for cystic fibrosis and inherited blood disorders, including sickle cell disease. Vertex Pharmaceuticals, in Boston, received rights to techniques known as CRISPR-Cas9 in a deal that could bring CRISPR Therapeutics, founded in April 2014, as much as…

  • First Results Released from Lung Fibrosis Registry

    22 October 2015. The first results from a registry of individuals with idiopathic pulmonary fibrosis show most people in the group have limited lung function and show symptoms for about a year before the disease is diagnosed. These findings and other characteristics of people taking part in the Idiopathic Pulmonary Fibrosis – PRospective Outcomes (IPF-PRO)…

  • Gates Grant Funding Whooping Cough Antibody Test

    21 October 2015. A protein engineering lab at University of Texas in Austin is evaluating the potential of an engineered antibody to prevent pertussis, also known as whooping cough, among newborn infants. The study and lab are led by chemical engineering professor Jennifer Maynard, who is testing the antibody under a $400,000 grant from the…

  • Evotec, Foundation Partner on Rare Juvenile Disease

    20 October 2015. The drug discovery company Evotec AG and Beyond Batten Disease Foundation are collaborating on discovery of new drugs to treat juvenile Batten disease, a rare inherited neurodegenerative disorder. Financial details of the partnership were not revealed. Batten disease is a rare genetic condition of the nervous system that in most cases begins…

  • Novartis Licensing Depression Therapy Technology

    19 October 2015. Luc Therapeutics, a biotechnology company designing treatments for psychiatric and neurological disorders, is licensing part of its technology to the pharmaceutical company Novartis to develop treatments for depression. Dollar amounts paid under the agreement to Luc Therapeutics, in Cambridge, Massachusetts, were not disclosed. Depression is a widespread condition, which when it becomes…

  • Cancer Institute Spins-Off Company, Gains Licensing Deal

    14 October 2015. Ontario Institute for Cancer Research is spinning off a new enterprise to discover therapies for blood-related cancers, and will partner with Janssen Biotech Inc. to take those therapies to market. The licensing deal between Novera Therapeutics Inc., the OICR spin-off company in Toronto, and Janssen Biotech, a division of Johnson & Johnson,…

  • Institute, GlaxoSmithKline ID Tuberculosis Candidates

    13 October 2015. A biomedical research institute partnered with a lab backed by pharmaceutical company GlaxoSmithKline to identify candidates for drugs that act on bacteria causing tuberculosis. The team from Center for Infectious Disease Research in Seattle and Tres Cantos Open Lab Foundation, a lab in Spain sponsored by GlaxoSmithKline, published its findings in a…

  • Eli Lilly Expanding NYC Labs for Cancer Therapies

    9 October 2015. The pharmaceutical company Eli Lilly and Company is expanding its research labs in New York City to boost discoveries of cancer therapies that harness the immune system. Lilly expects to hire 50 more research and support staff as part of the expansion. The company’s new facility will inhabit 30,000 square feet in…

  • MD Anderson, Biotech Form Antibody Discovery Company

    7 October 2015. MD Anderson Cancer Center in Houston is partnering with the biotechnology company Theraclone Sciences to form a new enterprise devoted to discovering antibodies for cancer therapies harnessing the immune system. The company named OncoResponse, also based in Houston, attracted $9.5 million in its first venture funding round. OncoResponse plans to adapt Theraclone’s…

  • Breakout Labs Adds Four Science-Based Start-Ups

    6 October 2015. Breakout Labs, an incubator of new enterprises based on discoveries from academic science labs, is adding four more companies to its portfolio. The new additions include companies developing advanced materials and sensors to measure food freshness, as well as discovering new therapies for diseases associated with the aging process. Breakout Labs is…